RG

Ramendra Goel

Director Director DIN 03526333
DIN 03526333 First appointment Aug 2013 Primary industry General Business
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 0 active board seats
Past companies 1 historical roles
Total affiliations 1 Since Aug 2013
Shareholding value Locked Premium profile

About Ramendra Goel

Data last updated:

Ramendra Goel has 13 years in corporate governance. Formerly with 1 company, such as Caventis Pharma Private Limited. Engaged in General Business. Contributes to corporate operations.

DIN 03526333
Primary Designation Director
First Appointment 27 Aug 2013
Oldest Company Age Not Provided

Current companies

No current companies available.

Previous companies

CompanyDesignationAppointmentFoundedStatus
Caventis Pharma Private Limited U51909DL2012PTC240513
Director27 Aug 20132012Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Caventis Pharma Private Limited
Premium access

Shareholding and investment profile for Ramendra Goel

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Ramendra Goel

Ramendra Goel has 13 years in corporate governance. Formerly with 1 company, such as Caventis Pharma Private Limited. Engaged in General Business. Contributes to corporate operations.

Ramendra Goel is associated with 0 companies as a director.

Ramendra Goel has expertise in General Business.

Ramendra Goel has 13 years in corporate governance.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available